You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 135 No. 10, October 1999 TABLE OF CONTENTS
  Archives
  •  Online Features
  Observation
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (4)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Nutritional and Metabolic Disorders
 •Nutritional and Metabolic Disorders, Other
 •Alert me on articles by topic

Migratory Ichthyosiform Dermatosis With Type 2 Diabetes Mellitus and Insulin Resistance

Gil Yosipovitch, MD; Baruch Mevorah, MD; Michael David, MD; Maora Feinmesser, MD; Emmilia Hodak, MD; Boaz Gabay, MD; Jamal Ammash, MD; Peter M. Elias, MD

Arch Dermatol. 1999;135:1237-1242.

Background  In addition to the well-defined hereditary primary ichthyoses, many sporadic or less well-defined keratinization disorders with or without systemic manifestations have been reported. Herein we describe ichthyosiform dermatosis associated with type 2 diabetes mellitus.

Observations  The patients were members of a large Arab family with heavy consanguinity. Eighteen members were affected with a variously severe scaly disorder. They showed migratory polycyclic keratotic scaly plaques evolving into diffuse generalized scaling or complete remission. Acanthosis nigricans–like lesions were also noted, and there was an association with type 2 diabetes mellitus. A scarcity of intercorneocyte lamellae and reduction in lamellar body contents were observed.

Conclusions  We could not find a report of a similar dermatosis. Furthermore, an association between ichthyosis and diabetes has not been documented. Therefore, we believe that this may constitute a new entity.


From the Departments of Dermatology (Drs Yosipovitch, David, Hodak, and Gabay) and Institute of Pathology (Dr Feinmesser), Rabin Medical Center, Petah Tiqva, Israel; Elias Sourasky Medical Center and the Sackler Faculty of Medicine, Tel Aviv, Israel (Drs Yosipovitch, Mevorah, David, Feinmesser, Hodak, and Gabay); Kupat–Hulim Clalit Gissar, Azarka, Israel (Dr Ammash); and Department of Dermatology, Veterans Affairs Medical Center, University of California, San Francisco (Dr Elias).


RELATED ARTICLE

Archives of Dermatology Reader's Choice: Continuing Medical Education
Arch Dermatol. 1999;135(10):1282-1283.
FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Skin barrier structure and function and their relationship to pruritus in end-stage renal disease
Yosipovitch et al.
Nephrol Dial Transplant 2007;22:3268-3272.
ABSTRACT | FULL TEXT  

Mutations in the transporter ABCA12 are associated with lamellar ichthyosis type 2
Lefevre et al.
Hum Mol Genet 2003;12:2369-2378.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1999 American Medical Association. All Rights Reserved.